Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Meti

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Cancers|June 20, 2018
The Role of Immune Checkpoint Inhibitors in Classical Hodgkin LymphomaNicholas Meti, Khashayar Esfahani, Nathalie A Johnson
Journal of Oncology Practice|July 14, 2018
Refractory Neutropenia Secondary to Dual Immune Checkpoint Inhibitors That Required Second-Line ImmunosuppressionNicholas Meti, Tina Petrogiannis-Haliotis, Khashayar Esfahani
JCO Clinical Cancer Informatics|June 10, 2021
Reply to A. Pfob et alNicholas Meti, Ali Sadeghi-Naini, William T Tran
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 16, 2019
Adverse events associated with immune checkpoint inhibitor treatment for cancerKhashayar Esfahani, Nicholas Meti, Wilson H Miller, et al.
Cancers|December 11, 2025
Current Immunotherapy Strategies and Emerging Biomarkers for the Treatment of Hepatocellular CarcinomaAudrey Kapelanski-Lamoureux, Anthoula Lazaris, Nicholas Meti, et al.
JCO Oncology Practice|May 14, 2020
Virtual Cancer Care During and Beyond the COVID-19 Pandemic: We Need to Get It RightNicholas Meti, Peter G Rossos, Matthew C Cheung, et al.
JCO Oncology Practice|July 1, 2020
Refractory Autoimmune Hemolytic Anemia and Pure Red Cell Aplasia Secondary to Immunotherapy Requiring Prolonged ImmunosuppressionMathew Hall, Nicholas Meti, Larissa Liontos, et al.
Heartrhythm Case Reports|May 12, 2017
Incessant atrioventricular nodal reentrant tachycardia with tachycardia-induced cardiomyopathy, biventricular thrombosis, and pulmonary emboliNicholas Meti, François-Pierre Mongeon, Peter G Guerra, et al.
Cancer Medicine|June 29, 2021
Quality of patient-reported outcomes in oncology clinical trials using immune checkpoint inhibitors: A systematic reviewEoghan Malone, Reeta Barua, Nicholas Meti, et al.
Cancer Treatment Reviews|September 16, 2021
Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysisRamy R Saleh, Michelle B Nadler, Alexandra Desnoyers, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Cancers|June 20, 2018
The Role of Immune Checkpoint Inhibitors in Classical Hodgkin LymphomaNicholas Meti, Khashayar Esfahani, Nathalie A Johnson
Journal of Oncology Practice|July 14, 2018
Refractory Neutropenia Secondary to Dual Immune Checkpoint Inhibitors That Required Second-Line ImmunosuppressionNicholas Meti, Tina Petrogiannis-Haliotis, Khashayar Esfahani
JCO Clinical Cancer Informatics|June 10, 2021
Reply to A. Pfob et alNicholas Meti, Ali Sadeghi-Naini, William T Tran
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 16, 2019
Adverse events associated with immune checkpoint inhibitor treatment for cancerKhashayar Esfahani, Nicholas Meti, Wilson H Miller, et al.
Cancers|December 11, 2025
Current Immunotherapy Strategies and Emerging Biomarkers for the Treatment of Hepatocellular CarcinomaAudrey Kapelanski-Lamoureux, Anthoula Lazaris, Nicholas Meti, et al.
JCO Oncology Practice|May 14, 2020
Virtual Cancer Care During and Beyond the COVID-19 Pandemic: We Need to Get It RightNicholas Meti, Peter G Rossos, Matthew C Cheung, et al.
JCO Oncology Practice|July 1, 2020
Refractory Autoimmune Hemolytic Anemia and Pure Red Cell Aplasia Secondary to Immunotherapy Requiring Prolonged ImmunosuppressionMathew Hall, Nicholas Meti, Larissa Liontos, et al.
Heartrhythm Case Reports|May 12, 2017
Incessant atrioventricular nodal reentrant tachycardia with tachycardia-induced cardiomyopathy, biventricular thrombosis, and pulmonary emboliNicholas Meti, François-Pierre Mongeon, Peter G Guerra, et al.
Cancer Medicine|June 29, 2021
Quality of patient-reported outcomes in oncology clinical trials using immune checkpoint inhibitors: A systematic reviewEoghan Malone, Reeta Barua, Nicholas Meti, et al.
Cancer Treatment Reviews|September 16, 2021
Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysisRamy R Saleh, Michelle B Nadler, Alexandra Desnoyers, et al.
Pageof 4